Literature DB >> 12188063

Prevalence of prostatitis-like symptoms in Singapore: a population-based study.

J K Tan1, D J C Png, L C H Liew, M K Li, M L Wong.   

Abstract

OBJECTIVE: To study the prevalence of prostatitis-like symptoms in a generally healthy population. SUBJECTS AND METHODS: A population-based cross-sectional survey was conducted in Singapore to evaluate "prostatitis-like symptoms" (PS), lower urinary tract symptoms (LUTS),erectile dysfunction (ED), and quality of life (QoL). Respondents with pain or discomfort in the perineum, testicles, tip of penis or bladder/suprapubic region were identified as having prostatitis-like symptoms.
RESULTS: Altogether, 1087 males aged 21 to 70 were evaluated. While at least 20% of them had some degree of LUTS, only 2.67% (29 out of 1087) had pain or discomfort suggestive of prostatitis. Six men had pain in the bladder or suprapubic region, two in the perineum, six at the tip of penis and 26 had pain during micturition (11 subjects had more than one location of pain). Only two men had severe pain while seven had moderate and the rest had mild pain. The mean age of subjects with PS was 43.14. In terms of racial distribution, 2.23% (18) of Chinese, 3.15% (4) of Malay, 4.49% (4) of Indians and 12.12% (3) of other ethnic origin had PS. Those who had PS had worse erectile function (International Index of Erectile Function (IIEF) 11.92 vs. 17.16, p < 0.003) and a worse QoL score (2.96 vs. 1.38, p < 0.001) than those without PS. Those with PS were more bothered and worried about their symptoms.
CONCLUSION: The prevalence of prostatitis-like symptoms in a largely Chinese population is 2.67%. Prostatitis-like symptoms have a negative impact on the quality of life and erectile function.

Entities:  

Mesh:

Year:  2002        PMID: 12188063

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  20 in total

Review 1.  Epidemiology of prostatitis: new evidence for a world-wide problem.

Authors:  John N Krieger; Donald E Riley; Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen
Journal:  World J Urol       Date:  2003-04-24       Impact factor: 4.226

Review 2.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

3.  Alpha-blockers for the treatment of prostatitis-like syndromes.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2006

Review 4.  Sexual dysfunction in the patient with prostatitis.

Authors:  Alexander Müller; John P Mulhall
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 5.  Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.

Authors:  Grzegorz Lukasz Fojecki; Stefan Tiessen; Palle Jörn Sloth Osther
Journal:  World J Urol       Date:  2016-04-23       Impact factor: 4.226

6.  An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.

Authors:  Jessica M Haverkamp; Bridget Charbonneau; Scott A Crist; David K Meyerholz; Michael B Cohen; Paul W Snyder; Robert U Svensson; Michael D Henry; Hsing-Hui Wang; Timothy L Ratliff
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

7.  alpha-Blockers for Treatment of the Prostatitis Syndromes.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2005

8.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

Review 9.  Epidemiology of prostatitis.

Authors:  John N Krieger; Shaun Wen Huey Lee; Jeonseong Jeon; Phaik Yeong Cheah; Men Long Liong; Donald E Riley
Journal:  Int J Antimicrob Agents       Date:  2007-12-31       Impact factor: 5.283

10.  The role of National Institutes of Health category IV prostatitis in accurately staging the newly diagnosed prostate cancer.

Authors:  E Aglamis; C Tasdemir; C Ceylan
Journal:  Ir J Med Sci       Date:  2013-02-01       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.